If you would like to earn credit, you must take the pre-test first by clicking here.

This activity was supported by educational grants from Bristol-Myers Squibb Company and Merck Sharp & Dohme Corp.

Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer Treatment

Anthony J. Olszanski, MD, RPh
Fox Chase Cancer Center

Krista M. Rubin, MS, FNP-BC
Massachusetts General Hospital

Review the basic concepts of immunotherapy and the current treatment landscape; explore important aspects of IO care, including the microbiome, provider-patient communication, and survivorship; and evaluate emerging data for ICI-based combinations that are being explored in late-stage clinical trials.


Download Slides


These activities, certified for CME/CE/CPE credit, are jointly provided by

Annenberg Logo Harborside Press Logo

in collaboration with

Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.